Clindamycin 150mg/mL (300 mg/2mL) Solution for Injection (I.M./I.V.)


Clindamycin 150mg/mL (300 mg/2mL) Solution for Injection (I.M./I.V.)

Enquire now!


    Clindamycin Phosphate is a clear colorless solution for injection filled in a clear glass ampoule.


    Each mL contains 182.93 mg clindamycin phosphate equivalent to 150 mg clindamycin.


    USP Type I clear and colorless glass ampoule x 2mL (net content). Box of 1’s.

    Indications & Dosage


    It is mainly bacteriostatic drug used in the treatment of serious anaerobic infections, notably due to Bacterodesfragilis. It is also used for Grand-positive infections due to pneumococci, staphylococci, streptococci such as liver abscess, actinomycosis, billary-tract infections, staphylococcal bone and joint infections, the carrier state of diphtheria, endophthalmis, gas gangrene, various gynaecological infections including bacterial vaginosis, endometritis and pelvic inflammatory disease, intra-abdominal infections including emphysema and pheumonia, septicaemia, and skin and soft-tissue infections involving heavy colonization with streptococci or anaerobes such as necrotizing fasciitis.

    Dosage and Administration

    Adults: Serious infections due to aerobic gram-positive cocci and the more susceptible anaerobes (NOT generally including Bacteroidesfragilis, Peptococcus species and Costridium perfringens): 600-1200mg/day in 2.3 or 4 equal doses either IM or Iv administration. More severe infections, particularly those due to proven or suspected Bacteroidesfragilis, Peptococcus species, or Clostridium species other than Clostridium perfringens:1200- 2700mg/day in 2,3 or 4 equal doses.

    For more serious infections, these doses may have to be increased. In life-thretening situations due to either aerobes or anaerobes these doses may be increased. Doses of as much as 4800mg daily have been given intravenously to adults.

    Neonates(Less than 1 month): 15 to 20mg/kg/day in 3 to 4 equal doses. The lower dosage may be adequate for small prematures.

    Pediatric patients 1 month of age to 16 years: 20 to 40mg/kg/day in 3 or 4 equal doses either IM or IV administration. The higher doses would be used for more severe infections. As an alternative to dosing on a body weight basis, pediatric patients may be dosed on the basis of square meters body surface: 350mg/m2/day for serious infections and 450mg/m2/day for more severe infections.

    Parenteral therapy may be changed to oral at the discretion of the physician. In cases of (beta)-
    hemolytic streptococcal infections, treatment should be continued for at least 10 days.Or as
    prescribed by the physician.

    See insert for complete information


    Distributed by:
    8F RBMT Bldg., Corner C3 and 5th Ave.,
    Grace Park, Caloocan City

    Imported by:
    Tinio St., San Nicolas,
    Gapan City, Nueva Ecija

    Manufactured by:
    Henan, China


    There are no reviews yet.

    Be the first to review “Klindarone”

    Your email address will not be published. Required fields are marked *

    Enquire now!